These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27913964)

  • 1. Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.
    Ravelli KG; Rosário BD; Camarini R; Hernandes MS; Britto LR
    Neurotox Res; 2017 Apr; 31(3):327-333. PubMed ID: 27913964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Liu C; Wu Y; Zha S; Liu M; Wang Y; Yang G; Ma K; Fei Y; Zhang Y; Hu X; Yang W; Qian Y
    Brain Res; 2016 Jan; 1631():137-46. PubMed ID: 26656068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
    Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
    J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol ameliorates learning and memory impairments induced by bilateral hippocampal injection of streptozotocin in mice.
    Wei YD; Chen XX; Yang LJ; Gao XR; Xia QR; Qi CC; Ge JF
    Neurochem Int; 2022 Oct; 159():105385. PubMed ID: 35843421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation.
    Fan M; Liu S; Sun HM; Ma MD; Gao YJ; Qi CC; Xia QR; Ge JF
    Biomed Pharmacother; 2022 Sep; 153():113375. PubMed ID: 35834993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model.
    Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
    Life Sci; 2017 Nov; 188():172-185. PubMed ID: 28867578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
    Du LL; Chai DM; Zhao LN; Li XH; Zhang FC; Zhang HB; Liu LB; Wu K; Liu R; Wang JZ; Zhou XW
    J Alzheimers Dis; 2015; 43(3):775-84. PubMed ID: 25114075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin.
    Santos TO; Mazucanti CH; Xavier GF; Torrão AS
    Physiol Behav; 2012 Oct; 107(3):401-13. PubMed ID: 22921433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
    Huang HC; Zheng BW; Guo Y; Zhao J; Zhao JY; Ma XW; Jiang ZF
    J Alzheimers Dis; 2016 Apr; 52(3):899-911. PubMed ID: 27060945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
    Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
    Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
    Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
    Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
    Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
    J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.
    Zhao HL; Cui SY; Qin Y; Liu YT; Cui XY; Hu X; Kurban N; Li MY; Li ZH; Xu J; Zhang YH
    J Ethnopharmacol; 2021 Apr; 269():113725. PubMed ID: 33352241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
    Ponce-Lopez T; Liy-Salmeron G; Hong E; Meneses A
    Brain Res; 2011 Dec; 1426():73-85. PubMed ID: 22036080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the Impact of Intracerebroventricular Streptozotocin on Female Rats with and without Ovaries: Implications for Alzheimer's Disease.
    López Hanotte J; Peralta F; Reggiani PC; Zappa Villar MF
    Neurochem Res; 2024 Oct; 49(10):2785-2802. PubMed ID: 38985243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH oxidase contributes to streptozotocin-induced neurodegeneration.
    Ravelli KG; Rosário BDA; Vasconcelos AR; Scavone C; Camarini R; Hernandes MS; Britto LR
    Neuroscience; 2017 Sep; 358():227-237. PubMed ID: 28687315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.
    Yeo HG; Lee Y; Jeon CY; Jeong KJ; Jin YB; Kang P; Kim SU; Kim JS; Huh JW; Kim YH; Sim BW; Song BS; Park YH; Hong Y; Lee SR; Chang KT
    J Alzheimers Dis; 2015; 46(4):989-1005. PubMed ID: 25881906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
    Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
    Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
    Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
    Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.